Predict your next investment

Cannamedical company logo
HEALTHCARE | Pharmaceuticals / Drugs
cannamedical.com

See what CB Insights has to offer

Total Raised

$30.18M

Investors Count

3

Cannamedical Funding, Cannamedical Valuation & Cannamedical Revenue

3 Fundings

Cannamedical's latest funding round was a Series B for $13.05M on April 20, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/20/2020

Series B

$13.05M

Steve Wiggins, and Undisclosed Investors

1

1/29/2019

Series A

$99M

10

1/2/2018

Seed VC

10

Date

4/20/2020

1/29/2019

1/2/2018

Round

Series B

Series A

Seed VC

Amount

$13.05M

$99M

Investors

Steve Wiggins, and Undisclosed Investors

Valuation

Revenue

Sources

1

10

10

Cannamedical Investors

3 Investors

Cannamedical has 3 investors. Steve Wiggins invested in Cannamedical's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/20/2020

4/20/2020

1
Series B

Angel Investor (Individual)

New York

00/00/0000

00/00/0000

Orkila Capital

Subscribe to see more

Subscribe to see more

Private Equity

New York

00/00/0000

00/00/0000

STATSnet Invests

Subscribe to see more

Venture Capital

Belgium

First funding

4/20/2020

00/00/0000

00/00/0000

Last Funding

4/20/2020

00/00/0000

00/00/0000

Investor

Orkila Capital

STATSnet Invests

Rounds

1
Series B

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Angel Investor (Individual)

Private Equity

Venture Capital

Location

New York

New York

Belgium

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.